Article Details
Retrieved on: 2021-11-15 19:06:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Previous therapies included anti-CD20 monoclonal antibodies (100%), ... 87% were refractory to their last anti-CD20 monoclonal antibody therapy.
Article found on: www.targetedonc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here